216 related articles for article (PubMed ID: 35843628)
1. Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review.
Singh P; Nambirajan A; Gaur MK; Raj R; Kumar S; Malik PS; Jain D
J Pathol Transl Med; 2022 Jul; 56(4):231-237. PubMed ID: 35843628
[TBL] [Abstract][Full Text] [Related]
2. Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring
Wang Z; Geng Y; Yuan LY; Wang MM; Ye CY; Sun L; Dai WP; Zang YS
Front Oncol; 2022; 12():761558. PubMed ID: 35237506
[TBL] [Abstract][Full Text] [Related]
3. Crizotinib in ALK
Theilen TM; Soerensen J; Bochennek K; Becker M; Schwabe D; Rolle U; Klingebiel T; Lehrnbecher T
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286567
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature.
Fu X; Jiang J; Tian XY; Li Z
Diagn Pathol; 2015 Jul; 10():106. PubMed ID: 26178751
[TBL] [Abstract][Full Text] [Related]
5. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
[TBL] [Abstract][Full Text] [Related]
6. Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib.
Li M; Xing R; Huang J; Shi C; Wei C; Wang H
Front Oncol; 2023; 13():1084456. PubMed ID: 37035183
[TBL] [Abstract][Full Text] [Related]
7. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
[TBL] [Abstract][Full Text] [Related]
8. ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report.
Xu X; Li H; Peng K; Yu Y; Chen L; Fang Y; Sun Y; Hou Y; Liu T
Oncol Lett; 2019 Feb; 17(2):2370-2376. PubMed ID: 30675302
[TBL] [Abstract][Full Text] [Related]
9. Epithelioid Inflammatory Myofibroblastic Sarcoma With Poor Response to Crizotinib: A Case Report.
Aminimoghaddam S; Pourali R
Clin Med Insights Case Rep; 2023; 16():11795476231163954. PubMed ID: 37841512
[TBL] [Abstract][Full Text] [Related]
10. Epithelioid inflammatory myofibroblastic sarcoma: a case report.
Sarmiento DE; Clevenger JA; Masters GA; Bauer TL; Nam BT
J Thorac Dis; 2015 Oct; 7(10):E513-6. PubMed ID: 26623133
[TBL] [Abstract][Full Text] [Related]
11. Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.
Yu L; Liu J; Lao IW; Luo Z; Wang J
Diagn Pathol; 2016 Jul; 11(1):67. PubMed ID: 27460384
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological features of inflammatory myofibroblastic tumor].
Zhu Y; Ding Y; Song GX; Li X; Ding R; Fan QH; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):194-200. PubMed ID: 33677881
[No Abstract] [Full Text] [Related]
13. Epithelioid inflammatory myofibroblastic sarcoma: a pitfall in the differential diagnosis of ALK-positive anaplastic large cell lymphoma.
Fadl A; Feldman AL
J Hematop; 2023 Jun; 16(2):125-126. PubMed ID: 37398940
[TBL] [Abstract][Full Text] [Related]
14. Epithelioid Inflammatory Myofibroblastic Sarcoma with Leukemoid Reaction.
Wan YY; Miao CL; Liu SB; Zhang T; Luo CH
J Coll Physicians Surg Pak; 2022 Sep; 32(9):1212-1215. PubMed ID: 36089724
[TBL] [Abstract][Full Text] [Related]
15. Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review.
Dou W; Guan Y; Liu T; Zheng H; Feng S; Wu Y; Wang X; Liu Z
Front Oncol; 2023; 13():1212529. PubMed ID: 37841422
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.
Du X; Gao Y; Zhao H; Li B; Xue W; Wang D
Oncol Lett; 2018 Jun; 15(6):9317-9326. PubMed ID: 29805657
[TBL] [Abstract][Full Text] [Related]
17. Epithelioid inflammatory myofibroblastic sarcoma of stomach: diagnostic pitfalls and clinical characteristics.
Xu P; Shen P; Jin Y; Wang L; Wu W
Int J Clin Exp Pathol; 2019; 12(5):1738-1744. PubMed ID: 31933992
[TBL] [Abstract][Full Text] [Related]
18. Abdominal inflammatory myofibroblastic tumour: Clinicopathological and molecular analysis of 20 cases, highlighting potential therapeutic targets.
Vernemmen AIP; Samarska IV; Speel EM; Riedl RG; Goudkade D; de Bruïne AP; Wouda S; van Marion AM; Verlinden IV; van Lijnschoten I; Friederich P; Winnepenninckx VJL; Zur Hausen A; Sciot RME; van den Hout MFCM
Histopathology; 2024 Apr; 84(5):794-809. PubMed ID: 38155480
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study.
Liu X; Gong C; Zhang J; Feng W; Guo Y; Sang Y; Wang C; Chen Y; Wang J; Yu L; Zhang X; Luo Z
Cancer Res Treat; 2023 Jul; 55(3):1001-1010. PubMed ID: 36915248
[TBL] [Abstract][Full Text] [Related]
20. A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib.
Kimbara S; Takeda K; Fukushima H; Inoue T; Okada H; Shibata Y; Katsushima U; Tsuya A; Tokunaga S; Daga H; Okuno T; Inoue T
Jpn J Clin Oncol; 2014 Sep; 44(9):868-71. PubMed ID: 25028698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]